National Institutes Of Health
Treatment opportunities for novel gram-negative antibiotics are rare in US hospitals
Treatment opportunities for novel gram-negative antibiotics are relatively infrequent in hospitals — representing just 39 to 138 days of therapy per 10,000 encounters, according to a study.
Women with BRCA mutations may be at higher risk for infertility after chemotherapy
Chemotherapy is known to increase a woman’s risk for infertility, and women with BRCA mutations have lower ovarian reserves and higher risk for developing breast cancer.
AACR forum confronts racism, inequality in research
As an oncologist who treats melanoma, Antoni Ribas, MD, PhD, typically views skin color from a strictly scientific perspective.
COVID-19 pandemic causing ‘unprecedented disruption’ in cancer research, Fauci says
The COVID-19 pandemic likely will have a significant long-term effect on the diagnosis and treatment of cancer, Anthony S. Fauci, MD, said today during an American Association for Cancer Research virtual meeting on COVID-19 and cancer.
Popular headache websites fail to comply with NIH readability guidelines
The first 10 websites found during a search of the words “headache” and “migraine” in the international version of Google featured content that required a reading level above what the NIH recommends, according to findings published in Headache.
Society for Immunotherapy of Cancer names fellowship, award recipients
COVID-19 may lead to 10,000 excess deaths due to breast, colorectal cancers
The COVID-19 pandemic will result in nearly 10,000 additional deaths due to breast cancer and colorectal cancer over the next decade, according to NCI projections.
Expansion of DRCR network opens new research opportunities
Since its inception in 2002, the Diabetic Retinopathy Clinical Research Network has initiated more than 30 clinical studies for the management and evaluation of diabetic retinopathy. In 2018, the network expanded its scope to include research of other retinal disorders, and in 2019, officially changed its name from DRCR.net to the DRCR Retina Network. The network has since opened its research doors to all retinal pathologies, an exciting prospect for network representatives, ophthalmic researchers and clinicians.
Gene therapy appears to reduce sickle cell disease-related complications
LentiGlobin gene therapy led to reductions in sickle cell disease-related complications and hemolysis, according to results of a phase 1/phase 2 trial presented at the virtual American Society of Gene and Cell Therapy Annual Meeting.
Despite NCI support, some cancer trials fail to publish health-related quality of life data
NCI has supported assessment of health-related quality of life in cancer clinical trials for approximately 30 years.